Skip to main content

Table 2 Age-standardized YLL, YLD, DALY rates and percentage change for Level 2 NCD-group, in Cyprus from 1990 to 2017

From: Burden of non-communicable diseases in Cyprus, 1990–2017: findings from the Global Burden of Disease 2017 study

  YLLs YLDs DALYs
1990 age-standardized rates per 100,000 2017 age-standardized rates per 100,000 Percentage change in age-standardized rates per 100,000 1990 age-standardized rates per 100,000 2017 age-standardized rates per 100,000 Percentage change in age-standardized rates per 100,000 1990 age-standardized rates per 100,000 2017 age-standardized rates per 100,000 Percentage change in age-standardized rates per 100,000
All causes 14,614 (14,339 - 14,887) 7904 (7332 - 8540) −45.9% 10,597 (7972 - 13,641) 10,383 (7841 - 13,374) − 2.0% 25,211 (22,605 - 28,229) 18,287 (15,607 - 21,322) −27.5%
Group II: Non-communicable diseases 10,793 (10,484 - 11,096) 6345 (5892 - 6856) −41.2% 8815 (6608 - 11,395) 8785 (6592 - 11,303) − 0.3% 19,608 (17,362 - 22,248) 15,129 (12,809 - 17,707) −22.8%
Cardiovascular diseases 4583 (4428 - 4752) 2171 (1981- 2389) −52.6% 397.1 (291.5–516.6) 326.2 (241–420.6) −17.9% 4980 (4787 - 5183) 2497 (2276- 2729) −49.9%
Neoplasms 2718 (2592 - 2828) 2327 (2150- 2523) −14.4% 81.7 (59.8–105.7) 142.2 (103.3–189.4) 74.1% 2800 (2673 - 2916) 2469 (2277- 2681) −11.8%
Musculoskeletal disorders 41.9 (30.3–51.3) 27 (20–32) −34.7% 2337 (1700 - 3151) 2337 (1692 - 3152) 0.0% 2379 (1740 - 3187) 2365 (1719 - 3177) −0.6%
Mental disorders 0.02 (0.01–0.02) 0.04 (0.02–0.05) 100.0% 1734 (1290 - 2246) 1732 (1283- 2239) −0.1% 1734 (1290 - 2246) 1732 (1284 - 2239) −0.1%
Neurological disorders 543.2 (500.6–578.8) 391.8 (362.2–423.6) −27.9% 1117 (761–1526) 1111 (748–1543) −0.5% 1660 (1310 - 2072) 1503 (1136 - 1932) −9.4%
Diabetes and kidney diseases 825.7 (758.4–901.3) 460.2 (417.4–505.6) −44.3% 494.9 (348.6–680) 539.8 (373–734.9) 9.1% 1321 (1156 - 1512) 1000 (832–1206) − 24.3%
Other non-communicable diseases 1020 (725–1272) 298.5 (262.1–333.6) −70.7% 679.6 (466.5–959.7) 595.6 (408.8–836.7) −12.4% 1699 (1314 - 2095) 894 (706.4–1133) −47.4%
Chronic respiratory diseases 519.2 (460.3–576.9) 311.2 (276.1–344.2) −40.0% 484.5 (374.5–605.4) 449.1 (352.8–556.9) −7.3% 1004 (880–1138) 760.7 (659.9–870.2) − 24.2%
Skin and subcutaneous diseases 19.7 (8.9–27.5) 17.1 (8.8–21.7) −13.2% 564.9 (383.1–809.4) 632.3 (433.7–902.8) 11.9% 584.7 (403.1–825.9) 649.4 (449.4–916.9) 11.1%
Sense organ diseases 0 0 N/A 531.5 (359.3–752.3) 501.8 (339.8–715.5) − 5.6% 531.5 (359.3–752.3) 501.8 (339.8–715.5) −5.6%
Digestive diseases 474.1 (380.6–570.6) 270.6 (241.7–302.6) −42.9% 204.5 (142.3–279.5) 217.4 (152–298) 6.3% 678.7 (557.4–799.7) 488 (419.4–576.7) −28.1%
Substance use disorders 48 (37.9–61.2) 69.3 (59–84) 44.1% 188.1 (131.1–252.3) 199.7 (138.3–266.2) 6.2% 236.2 (178–298.7) 268.9 (208.8–333.9) 13.9%
  1. Data in parentheses are 95% uncertainty intervals (UIs)
  2. A positive percentage change indicates an increase and a negative change a decrease between 1990 and 2017
  3. DALYs disability-adjusted life years, YLLs years of life lost, YLDs years lived with disability, N/A not applicable